1. K-State home
  2. »Research Compliance
  3. »IRB

Institutional Review Board

FDA Investigational New Drug (IND)

Resources for IND Applications:

The following resources include:

Once the IND is submitted, the sponsor must wait 30 calendar days before initiating any clinical trials. During this time, the FDA has an opportunity to review the IND for safety to assure that research subjects will not be subjected to unreasonable risk.